Sun Pharma, SPARC shares surge up to 7% after USFDA gives approval for Xelpros drug
In a joint statement on Friday, Sun Pharma and its research arm SPARC said the USFDA has approved its new drug application of Xelpros.
from The Financial ExpressThe Financial Express https://ift.tt/2Mu7nvV
via IFTTT
from The Financial ExpressThe Financial Express https://ift.tt/2Mu7nvV
via IFTTT